Hair transplant costs $150,000 for hair transplant costs, experts say
A $150 million hair transplant operation for a patient with cancer could be delayed, leading to a higher cost and an increased risk of infection.
The Royal Australasian College of Gynaecologists (RACG) has warned that the costs of a successful hair transplant could be up to $1 million a day if a patient is not well enough to undergo the operation.
Key points:Gynaecologist and surgeon Dr Peter Nye is one of the first to operate on a hair transplant patientGynaemologist Dr Peter Sneddon has described the procedure as “incredibly expensive”The RACG has recommended that patients who are already cancer-free undergo a hair transplants operation at a cost of between $150 and $200,000The surgery was carried out by the world’s largest hair transplant centre, and was performed in the US.
The centre is part of the US National Institutes of Health (NIH) which has made the decision to wait for the best results from the transplant surgery, rather than make a major investment.
“This is a highly complex surgery, and one that is only minimally covered by health insurers,” Dr Nye told ABC Radio Perth.
“It requires the best clinical judgment from the surgeon, who will have to be able to get the right patient into the right position and then, depending on how many grafts are needed, they will need to be placed in the right way.”
“I would say that it would be a very high price for the patient, but the risk of this being a one-off operation is really low,” he said.
“We do not know the exact cost of the operation in terms of the money and the risk, but it could be significantly higher than that.”
There is very little chance that it is going to happen at any other time.”‘
The surgeon has got the best chance’The decision to postpone the operation came after Dr Nys had been given a call from a woman in New Zealand who was undergoing a hair restoration procedure.”
She was in a very bad state of health, and it was really important that she was able to go into this procedure,” Dr Snedden said.”[The surgeon] had got the first graft in, and she was going to go in at six weeks and have a very aggressive hair transplant.
“I said to the surgeon I am going to call the surgeon to get a better opinion, and he said he has got a good chance of getting this done, and we should just put it on hold.”
Dr Nye said the surgery would be the best outcome for the surgery and the patient.
“The surgeon would have the best shot at this operation, because he would have done the graft in a way that would allow the patient to get her hair back, and that is what we would expect,” he told ABC Perth.
The operation was carried on at a facility in the United States, and has received high marks from the medical profession.
“What I have seen over the past few years is a lot of people going to have very aggressive surgery and really aggressive treatment, and I think that is very important,” Dr Peter said.
The surgery will be carried out at the Massachusetts General Hospital in Boston, and will be overseen by Dr Nydons team of six.
Dr Sneddens team is also leading the hair transplant at the National Institutes for Health (NIA), which is the main funding agency for the procedure.
The National Institute for Health and Care Excellence (NICE), which includes the Australian Health and Medical Research Council (AHPRC), the US Food and Drug Administration (FDA) and the US Environmental Protection Agency (EPA), are responsible for overseeing the clinical trials, which have been held at the University of Massachusetts Medical School.
The first trial was conducted in November 2017.
“They [NICE] have made a very positive contribution in that trial and in this one, they have really done an amazing job,” Dr Chris Lough, head of the Australian Hair transplant team, said.
Dr Lough said the success of the trial was the best that the research community could hope for.
“That was really the beginning of the research that has been conducted over the last few years to try and understand whether this is a viable option for the majority of patients in Australia,” he added.
“At the end of the day, we need to find out whether there is a benefit in this type of surgery for these patients.”
The RASG is a group of Australian medical experts, who advise on the care of patients with cancer.
Dr Nys said the patient had been told to expect a high cost, and the surgery could be very expensive.
“People in the population that we are working with are quite high risk and it is a very, very complicated operation, and there is very, high risk that they are going to need to go through a lot more grafts,” he